Prognostic Significance of Tumor Necrosis in Patients with Gallbladder Carcinoma Undergoing Curative-Intent Resection

被引:4
|
作者
Yang, Si-qi [1 ]
Wang, Jun-ke [1 ]
Ma, Wen-jie [1 ]
Liu, Fei [1 ]
Zou, Rui-qi [1 ]
Dai, Yu-shi [1 ]
Lv, Tian-run [1 ]
Li, Fu-yu [1 ]
Hu, Hai-jie [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Gen Surg, Div Biliary Tract Surg, Chengdu, Sichuan, Peoples R China
关键词
CANCER; INFILTRATION; MACROPHAGES; SURVIVAL;
D O I
10.1245/s10434-023-14421-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Tumor necrosis has been indicated to correlate with dismal survival outcomes of a variety of solid tumors. However, the significance and prognostic value of tumor necrosis remain unclear in gallbladder carcinoma. The aim of this research is to explore the relationships between necrosis with long-term survival and tumor-related biological characteristics of patients with gallbladder carcinoma.Patients and Methods. Patients with gallbladder carcinoma who accepted curative-intent resection in West China Hospital of Sichuan University (China) between January 2010 and December 2021 were retrospectively analyzed. Tumor necrosis was determined by staining the patient's original tissue sections with hematoxylin and eosin. Based on the presence of tumor necrosis, the pathologic features and survival outcomes were compared.Results. This study enrolled 213 patients with gallbladder carcinoma who underwent curative-intent surgery, of whom 89 had tumor necrosis. Comparative analyses indicated that patients with tumor necrosis had more aggressive clinicopathological features, such as larger tumor size (p = 0.002), poorer tumor differentiation (p = 0.029), more frequent vascular invasion (p < 0.001), presence of lymph node metastasis (p = 0.014), and higher tumor status (p = 0.01), and experienced poorer survival. Univariate and multivariate analyses revealed that tumor necrosis was an independent prognostic factor for overall survival (multivariate: HR 1.651, p = 0.026) and disease-free survival (multivariate: HR 1.589, p = 0.040).Conclusions. Tumor necrosis can be considered as an independent predictive factor for overall survival and disease-free survival among individuals with gallbladder carcinoma, which was a valuable pathologic parameter.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 50 条
  • [31] Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection
    Li, Qian
    Wei, Yi
    Che, Feng
    Zhang, Tong
    Yao, Shan
    Zhao, Jian
    Zhang, YuHui
    Tang, Hehan
    Song, Bin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Metachronous Ampulla of Vater Carcinoma after Curative-Intent Surgery for Klatskin Tumor
    Chirita, D.
    Calita, M.
    Grasu, M.
    Dumitru, R.
    Gramaticu, I.
    Croitoru, A.
    Ionescu, M.
    Dumitrascu, T.
    CHIRURGIA, 2015, 110 (04) : 379 - 383
  • [33] Surveillance for ovarian carcinoma patients after curative-intent treatment.
    Johnson, F. E.
    Virgo, K. S.
    Gao, F.
    Mutch, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Comment: "Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma"
    Wang, Yuxin
    Du, Shunda
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (06) : 1137 - 1138
  • [35] The Advanced Lung Cancer Inflammation Index Is a Prognostic Marker in Patients Undergoing Curative-Intent Therapy for Lung Cancer
    Cypro, A.
    Fuster, M. M.
    Montgrain, P. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
    Lima, Henrique A.
    Alaimo, Laura
    Brown, Zachary J.
    Endo, Yutaka
    Moazzam, Zorays
    Tsilimigras, Diamantis I.
    Shaikh, Chanza
    Resende, Vivian
    Guglielmi, Alfredo
    Ratti, Francesca
    Aldrighetti, Luca
    Marques, Hugo P.
    Soubrane, Olivier
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Hugh, Tom
    Endo, Itaru
    Shen, Feng
    Pawlik, Timothy M.
    HPB, 2023, 25 (02) : 260 - 268
  • [37] Evaluation of Lymph Nodes for Patients Undergoing Curative Intent Resection for Adrenocortical Adenocarcinoma: Therapeutic or Prognostic?
    Deschner, Benjamin W.
    Stiles, Zachary E.
    DeLozier, Olivia M.
    Glazer, Evan S.
    Deneve, Jeremiah L.
    Yakoub, Danny
    Dickson, Paxton V.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S77 - S77
  • [38] Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas
    Sallinen, V
    Siren, J.
    Makisalo, H.
    Lehtimaki, T. E.
    Lantto, E.
    Kokkola, A.
    Nordin, A.
    SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (03) : 219 - 227
  • [39] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
    Oettle, Helmut
    Post, Stefan
    Neuhaus, Peter
    Gellert, Klaus
    Langrehr, Jan
    Ridwelski, Karsten
    Schramm, Harald
    Fahlke, Joerg
    Zuelke, Carl
    Burkart, Christof
    Gutberlet, Klaus
    Kettner, Erika
    Schmalenberg, Harald
    Weigang-Koehler, Karin
    Bechstein, Wolf-Otto
    Niedergethmann, Marco
    Schmidt-Wolf, Ingo
    Roll, Lars
    Doerken, Bernd
    Riess, Hanno
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03): : 267 - 277
  • [40] A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
    Merath, Katiuscha
    Chen, Qinyu
    Bagante, Fabio
    Alexandrescu, Sorin
    Marques, Hugo P.
    Aldrighetti, Luca
    Maithel, Shishir K.
    Pulitano, Carlo
    Weiss, Matthew J.
    Bauer, Todd W.
    Shen, Feng
    Poultsides, George A.
    Soubrane, Olivier
    Martel, Guillaume
    Koerkamp, B. Groot
    Guglielmi, Alfredo
    Itaru, Endo
    Cloyd, Jordan M.
    Pawlik, Timothy M.
    JAMA SURGERY, 2019, 154 (06)